-
Je něco špatně v tomto záznamu ?
Participation in pharmaceutical costs and seniors' access to medicines in the Czech Republic
Jana Davidová, Natasa Ivanovic, Lenka Práznovcová
Jazyk angličtina Země Česko
Typ dokumentu rozhovory
Digitální knihovna NLK
Plný text - Článek
Číslo
Ročník
Zdroj
Zdroj
NLK
Free Medical Journals
od 2004
Medline Complete (EBSCOhost)
od 2006-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources
od 1993
- MeSH
- dostupnost zdravotnických služeb ekonomika zákonodárství a právo MeSH
- financování organizované využití MeSH
- interpretace statistických dat MeSH
- náklady na léky statistika a číselné údaje trendy zákonodárství a právo MeSH
- poplatky farmaceutické normy statistika a číselné údaje zákonodárství a právo MeSH
- poplatky lékařské statistika a číselné údaje zákonodárství a právo MeSH
- senioři statistika a číselné údaje MeSH
- Check Tag
- senioři statistika a číselné údaje MeSH
- Publikační typ
- rozhovory MeSH
- Geografické názvy
- Česká republika MeSH
Objectives: Analysis of participation in drug costs by seniors in the Czech Republic in connection with seniors' access to pharmacotherapy. Materials and methods: Quota-sampled guided interview with 450 respondents visiting pharmacy; ratio of men and women approximately 1:2; age over 60 years; 3 regions of the Czech Republic. Results: Respondent's income was retirement pension in 80 %. More than 55% of respondents did not reach the official state average. Respondents used altogether 1,650 medicines on physician's prescription in the last four weeks. Overall co-payment for medicines was 38,778 CZK, i.e. 86 CZK per patient. Only 27% of respondents used fully reimbursed products. Respondents used together 273 OTC drugs (over-the-counter drugs, e.g. non prescription drugs) in value of 16,540 CZK, i.e. 37 CZK per patient. Average respondent spent on medicines 123 CZK in the last four weeks, i.e. 1.5% of the official state average income. There were respondents, about 10%, searching for the level of co-payment in several pharmacies and more than 8% of respondents had to refuse dispensation of medicines due to co-payment. Conclusions: Our study demonstrates that there are patients who may fail to gain access to medication due to co-payment in the Czech Republic. The financial participation in health care costs is generally low in the Czech Republic (8.8% of total health expenditures) but there were differences in co-payment levels in patients ranging from 1 CZK to thousands CZK. In our opinion problem might be in the absence of any instrument limiting the highest individual participation as it is for example in 12-month period in Sweden. In our study co-payments were lower in smaller communities that may be due to better communication between physicians and patients or physicians and pharmacists. We found a critical ethical problem in different levels of co-payment of concrete product.
Citace poskytuje Crossref.org
Lit.: 16
- 000
- 03951naa 2200421 a 4500
- 001
- bmc07509261
- 003
- CZ-PrNML
- 005
- 20111210123442.0
- 008
- 080923s2008 xr e eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a3439 $2 doi
- 035 __
- $a (PubMed)18459476
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Davidová, Jana. $7 _BN005945
- 245 10
- $a Participation in pharmaceutical costs and seniors' access to medicines in the Czech Republic / $c Jana Davidová, Natasa Ivanovic, Lenka Práznovcová
- 314 __
- $a Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University in Prague
- 504 __
- $a Lit.: 16
- 520 9_
- $a Objectives: Analysis of participation in drug costs by seniors in the Czech Republic in connection with seniors' access to pharmacotherapy. Materials and methods: Quota-sampled guided interview with 450 respondents visiting pharmacy; ratio of men and women approximately 1:2; age over 60 years; 3 regions of the Czech Republic. Results: Respondent's income was retirement pension in 80 %. More than 55% of respondents did not reach the official state average. Respondents used altogether 1,650 medicines on physician's prescription in the last four weeks. Overall co-payment for medicines was 38,778 CZK, i.e. 86 CZK per patient. Only 27% of respondents used fully reimbursed products. Respondents used together 273 OTC drugs (over-the-counter drugs, e.g. non prescription drugs) in value of 16,540 CZK, i.e. 37 CZK per patient. Average respondent spent on medicines 123 CZK in the last four weeks, i.e. 1.5% of the official state average income. There were respondents, about 10%, searching for the level of co-payment in several pharmacies and more than 8% of respondents had to refuse dispensation of medicines due to co-payment. Conclusions: Our study demonstrates that there are patients who may fail to gain access to medication due to co-payment in the Czech Republic. The financial participation in health care costs is generally low in the Czech Republic (8.8% of total health expenditures) but there were differences in co-payment levels in patients ranging from 1 CZK to thousands CZK. In our opinion problem might be in the absence of any instrument limiting the highest individual participation as it is for example in 12-month period in Sweden. In our study co-payments were lower in smaller communities that may be due to better communication between physicians and patients or physicians and pharmacists. We found a critical ethical problem in different levels of co-payment of concrete product.
- 650 _2
- $a senioři $x statistika a číselné údaje $7 D000368
- 650 _2
- $a poplatky farmaceutické $x normy $x statistika a číselné údaje $x zákonodárství a právo $7 D005252
- 650 _2
- $a poplatky lékařské $x statistika a číselné údaje $x zákonodárství a právo $7 D005251
- 650 _2
- $a náklady na léky $x statistika a číselné údaje $x trendy $x zákonodárství a právo $7 D016527
- 650 _2
- $a dostupnost zdravotnických služeb $x ekonomika $x zákonodárství a právo $7 D006297
- 650 _2
- $a interpretace statistických dat $7 D003627
- 650 _2
- $a financování organizované $x využití $7 D005381
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a rozhovory $7 D017203
- 700 1_
- $a Ivanovič, Nataša $7 xx0118782
- 700 1_
- $a Práznovcová, Lenka, $d 1962-2010 $7 jo20000076519
- 773 0_
- $w MED00001083 $t Central European journal of public health $g Roč. 16/52, č. 1 (2008), s. 26-28 $x 1210-7778
- 856 41
- $u http://www.szu.cz/svi/cejph/archiv/2008-1-06.pdf $y plný text volně přístupný
- 910 __
- $y 1 $a ABA008 $b B 1829 $c 562
- 990 __
- $a 20080923083420 $b ABA008
- 991 __
- $a 20100602112540 $b ABA008
- 999 __
- $a ok $b bmc $g 624852 $s 477287
- BAS __
- $a 3
- BMC __
- $a 2008 $b 16 $c 1 $d 26-28 $i 1210-7778 $m Central European Journal of Public Health $x MED00001083
- LZP __
- $a 2008-31/vtal